- Report
- July 2026
- 180 Pages
Global
From €4284EUR$4,750USD£3,673GBP
- Report
- November 2025
- 160 Pages
Global
From €2850EUR$3,160USD£2,444GBP
€3563EUR$3,950USD£3,055GBP
- Report
- September 2026
United States
From €3599EUR$3,990USD£3,085GBP
- Report
- September 2026
Europe
From €3599EUR$3,990USD£3,085GBP
- Report
- September 2026
Middle East
From €3599EUR$3,990USD£3,085GBP
- Report
- September 2026
Asia Pacific
From €3599EUR$3,990USD£3,085GBP
- Report
- September 2026
- 189 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- February 2026
- 250 Pages
Global
From €4050EUR$4,490USD£3,472GBP
- Report
- September 2026
- 268 Pages
Global
From €4915EUR$5,450USD£4,214GBP
- Report
- March 2025
- 227 Pages
Global
From €2255EUR$2,500USD£1,933GBP
- Report
- September 2026
China
From €3599EUR$3,990USD£3,085GBP
- Report
- September 2026
United Kingdom
From €3599EUR$3,990USD£3,085GBP
- Report
- September 2026
Global
From €3599EUR$3,990USD£3,085GBP
- Report
- September 2026
North America
From €3599EUR$3,990USD£3,085GBP
- Report
- September 2026
Europe
From €3599EUR$3,990USD£3,085GBP
The Blood Grouping Reagent market is a subset of the Blood Banking industry. It is composed of products used to identify the ABO and Rh blood group of a patient. These reagents are used to determine the compatibility of a patient's blood with a potential donor's blood, and are essential for successful transfusions. The market is composed of a variety of reagents, including monoclonal and polyclonal antibodies, lectins, and enzymes. These reagents are used in a variety of tests, such as agglutination, precipitation, and ELISA.
The Blood Grouping Reagent market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Immucor, Grifols, Ortho Clinical Diagnostics, Bio-Rad Laboratories, and DiaMed. Show Less Read more
